Recent quotes:

Putting Diabetes Into Remission; Does Prehabilitation Work? | MedPage Today

There are all three available, but only two of which have been shown to have cardioprotective effects. What we had presupposed was that anything that lowered the hemoglobin A1C would be beneficial, and the more you lowered it, the more beneficial it would be. Even though the SGLT2 inhibitors had smaller reductions in A1C, they were the ones that were most effective in the older population, so there's not a direct correlation. Furthermore, only two of the three showed cardioprotective effects. The DPP-4 inhibitors did not show cardioprotective effects, even though they were just as effective on lowering in the A1C.